Results 11 to 20 of about 31,959 (340)

Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China. [PDF]

J Infect, 2022
Xu B, Ma FQ, He C, Wu ZQ, Fan CY, Mao HR, Zhang JX, Yang M, Hu ZW.   +8 more
europepmc   +4 more sources

Reference values for lung function tests: III. Carbon monoxide diffusing capacity (transfer factor) [PDF]

Brazilian Journal of Medical and Biological Research, 1999
Carbon monoxide diffusing capacity (DLCO) or transfer factor (TLCO) is a particularly useful test of the appropriateness of gas exchange across the lung alveolocapillary membrane. With the purpose of establishing predictive equations for DLCO using a non-
Neder J.A., Andreoni S., Peres C., Nery L.E.   +3 more
doaj   +3 more sources

The pulmonary diffusing capacity in normal subjects [PDF]

The Journal of Physiology, 1955
David V. Bates, Nancy G. Boucot, A. E. Dormer   +2 more
openalex   +4 more sources

Pulmonary diffusing capacity among individuals recovering from mild to moderate COVID-19: a cross-sectional study. [PDF]

Sci Rep
Yelin D, Ghantous N, Awwad M, Daitch V, Kalfon T, Mor M, Buchrits S, Shafir Y, Shapira-Lichter I, Leibovici L, Yahav D, Margalit I, Shitenberg D.   +12 more
europepmc   +3 more sources

PULMONARY DIFFUSING CAPACITY IN MITRAL VALVE DISEASE [PDF]

Heart, 1963
J. M. Reid, James G. Stevenson
openalex   +4 more sources

Interferon-signaling pathways are upregulated in people with HIV with abnormal pulmonary diffusing capacity (DL CO ). [PDF]

AIDS
Zhang M, Dai G, Smith DL, Zacco E, Shimoda M, Kumar N, Girling V, Gardner K, Hunt PW, Huang L, Lin J.   +10 more
europepmc   +3 more sources

Simultaneous Measurement of Lung Diffusing Capacity and Pulmonary Hemodynamics Reveals Exertional Alveolar‐Capillary Dysfunction in Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Hemodynamic perturbations in heart failure with preserved ejection fraction (HFpEF) may alter the distribution of blood in the lungs, impair gas transfer from the alveoli into the pulmonary capillaries, and reduce lung diffusing capacity.
Caitlin C. Fermoyle, Glenn M. Stewart, Barry A. Borlaug, Bruce D. Johnson   +3 more
doaj   +1 more source

Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion [PDF]

Jornal Brasileiro de Pneumologia, 2023
Objective: Lymphangioleiomyomatosis (LAM) is a rare, destructive disease of the lungs with a limited number of determinants of disease activity, which are a critical need for clinical trials.
Anthony J Esposito, Jewel Imani, Shikshya Shrestha, Shefali Bagwe, Anthony M Lamattina, Marina Vivero, Hilary J Goldberg, Ivan O Rosas, Elizabeth P Henske, Souheil Y El-Chemaly   +9 more
doaj   +1 more source

Pseudoxanthoma Elasticum - Also a Lung Disease? The Respiratory Affection of Patients with Pseudoxanthoma Elasticum. [PDF]

PLoS ONE, 2016
BACKGROUND:Pseudoxanthoma elasticum (PXE) is an autosomal-recessive mineralisation disorder caused by loss of function mutations in the ABCC6 Gen. Histological findings and data of an autopsy of a PXE-patient suggest a possible pulmonal calcification. So
Simon Pingel, Sebastian Gorgonius Passon, Kristin Solveig Pausewang, Anna Katharina Blatzheim, Carmen Pizarro, Izabela Tuleta, Martin Gliem, Peter Charbel Issa, Nadjib Schahab, Georg Nickenig, Dirk Skowasch, Christian Alexander Schaefer   +11 more
doaj   +1 more source

Alveolar-membrane diffusing capacity limits performance in Boston marathon qualifiers. [PDF]

PLoS ONE, 2012
PURPOSE: (1) to examine the relation between pulmonary diffusing capacity and marathon finishing time, and (2), to evaluate the accuracy of pulmonary diffusing capacity for nitric oxide (DLNO) in predicting marathon finishing time relative to that of ...
Kaleen M Lavin, Allison M Straub, Kathleen A Uhranowsky, James M Smoliga, Gerald S Zavorsky   +4 more
doaj   +1 more source